ANDREADOU, IOANNA
ANDREADOU, IOANNA
SCIENZE MEDICHE
Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus
2019-01-01 Abu Qourah, F; Nikolaou, PE ; Femmino, S; Tsoumani, M; Varela, A; Davos, C; Dimitriou, C; Kanaki, Z; Dimitriadis, G; Brizzi, MF; Iliodromitis EK; Andreadou, I
Chronic Empaglifozin treatment reduces myocardial infarct size in non-diabetic mice through STAT-3 mediated protection on microvascular endothelial cells and reduction of oxidative stress.
2021-01-01 Nikolaou PE, Efentakis P, Qourah FA, Femminò S, Makridakis M, Kanaki Z, Varela A, Tsoumani M, Davos CH, Dimitriou CA, Tasouli A, Dimitriadis G, Kostomitsopoulos N, Zuurbier CJ, Vlahou A, Klinakis A, Brizzi MF, Iliodromitis EK, Andreadou I.
Circulating blood cells and extracellular vesicles in acute cardioprotection
2019-01-01 Davidson S.M.; Andreadou I.; Barile L.; Birnbaum Y.; Cabrera-Fuentes H.A.; Cohen M.V.; Downey J.M.; Girao H.; Pagliaro P.; Penna C.; Pernow J.; Preissner K.T.; Ferdinandy P.
Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs
2020-01-01 Rosa A.C.; Mio M.; Andreadou I.; Sumbayev V.V.
Effect of hyperglycaemia and diabetes on acute myocardial ischaemia–reperfusion injury and cardioprotection by ischaemic conditioning protocols
2020-01-01 Penna C.; Andreadou I.; Aragno M.; Beauloye C.; Bertrand L.; Lazou A.; Falcao-Pires I.; Bell R.; Zuurbier C.J.; Pagliaro P.; Hausenloy D.J.
Empagliflozin limits myocardial infarction in vivo and cell death in vitro: Role of STAT3, mitochondria, and redox aspects
2017-01-01 Andreadou, Ioanna; Efentakis, Panagiotis; Balafas, Evangelos; Togliatto, Gabriele; Davos, Constantinos H.; Varela, Aimilia; Dimitriou, Constantinos A.; Nikolaou, Panagiota-Efstathia; Maratou, Eirini; Lambadiari, Vaia; Ikonomidis, Ignatios; Kostomitsopoulos, Nikolaos; Brizzi, Maria F.; Dimitriadis, George; Iliodromitis, Efstathios K.
Immunometabolism in heart failure
2025-01-01 Andreadou, Ioanna; Ghigo, Alessandra; Nikolaou, Panagiota-Efstathia; Swirski, Filip K; Thackeray, James T; Heusch, Gerd; Vilahur, Gemma
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
2021-01-01 Lecour, Sandrine; Andreadou, Ioanna; Bøtker, Hans Erik; Davidson, Sean M; Heusch, Gerd; Ruiz-Meana, Marisol; Schulz, Rainer; Zuurbier, Coert J; Ferdinandy, Péter; Hausenloy, Derek J
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning
2025-01-01 Hernandez-Resendiz, Sauri; Vilskersts, Reinis; Aluja, David; Andreadou, Ioanna; Bencsik, Péter; Dambrova, Maija; Efentakis, Panagiotis; Gao, Fei; Giricz, Zoltán; Inserte, Javier; Kelly-Laubscher, Roisin; Kiss, Attila; Krieg, Thomas; Kwak, Brenda R; Lecour, Sandrine; Lopaschuk, Gary; Mączewski, Michał; Waszkiewicz, Michał; Oknińska, Marta; Pagliaro, Pasquale; Podesser, Bruno; Prag, Hiran A; Ruiz-Meana, Marisol; Szabados, Tamara; Zuurbier, Coert J; Ferdinandy, Péter; Hausenloy, Derek J
Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: Role of cardiac redox signaling
2021-01-01 Andreadou I.; Daiber A.; Baxter G.F.; Brizzi M.F.; Di Lisa F.; Kaludercic N.; Lazou A.; Varga Z.V.; Zuurbier C.J.; Schulz R.; Ferdinandy P.
Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?
2024-01-01 Bellofatto I.A.; Nikolaou P.E.; Andreadou I.; Canepa M.; Carbone F.; Ghigo A.; Heusch G.; Kleinbongard P.; Maack C.; Podesser B.K.; Stamatelopoulos K.; Stellos K.; Vilahur G.; Montecucco F.; Liberale L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus | 2019 | Abu Qourah, F; Nikolaou, PE ; Femmino, S; Tsoumani, M; Varela, A; Davos, C; Dimitriou, C; Kanaki, Z; Dimitriadis, G; Brizzi, MF; Iliodromitis EK; Andreadou, I | |
| Chronic Empaglifozin treatment reduces myocardial infarct size in non-diabetic mice through STAT-3 mediated protection on microvascular endothelial cells and reduction of oxidative stress. | 2021 | Nikolaou PE, Efentakis P, Qourah FA, Femminò S, Makridakis M, Kanaki Z, Varela A, Tsoumani M, Davos CH, Dimitriou CA, Tasouli A, Dimitriadis G, Kostomitsopoulos N, Zuurbier CJ, Vlahou A, Klinakis A, Brizzi MF, Iliodromitis EK, Andreadou I. | |
| Circulating blood cells and extracellular vesicles in acute cardioprotection | 2019 | Davidson S.M.; Andreadou I.; Barile L.; Birnbaum Y.; Cabrera-Fuentes H.A.; Cohen M.V.; Downey J.M.; Girao H.; Pagliaro P.; Penna C.; Pernow J.; Preissner K.T.; Ferdinandy P. | |
| Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs | 2020 | Rosa A.C.; Mio M.; Andreadou I.; Sumbayev V.V. | |
| Effect of hyperglycaemia and diabetes on acute myocardial ischaemia–reperfusion injury and cardioprotection by ischaemic conditioning protocols | 2020 | Penna C.; Andreadou I.; Aragno M.; Beauloye C.; Bertrand L.; Lazou A.; Falcao-Pires I.; Bell R.; Zuurbier C.J.; Pagliaro P.; Hausenloy D.J. | |
| Empagliflozin limits myocardial infarction in vivo and cell death in vitro: Role of STAT3, mitochondria, and redox aspects | 2017 | Andreadou, Ioanna; Efentakis, Panagiotis; Balafas, Evangelos; Togliatto, Gabriele; Davos, Constantinos H.; Varela, Aimilia; Dimitriou, Constantinos A.; Nikolaou, Panagiota-Efstathia; Maratou, Eirini; Lambadiari, Vaia; Ikonomidis, Ignatios; Kostomitsopoulos, Nikolaos; Brizzi, Maria F.; Dimitriadis, George; Iliodromitis, Efstathios K. | |
| Immunometabolism in heart failure | 2025 | Andreadou, Ioanna; Ghigo, Alessandra; Nikolaou, Panagiota-Efstathia; Swirski, Filip K; Thackeray, James T; Heusch, Gerd; Vilahur, Gemma | |
| IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action | 2021 | Lecour, Sandrine; Andreadou, Ioanna; Bøtker, Hans Erik; Davidson, Sean M; Heusch, Gerd; Ruiz-Meana, Marisol; Schulz, Rainer; Zuurbier, Coert J; Ferdinandy, Péter; Hausenloy, Derek J | |
| IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning | 2025 | Hernandez-Resendiz, Sauri; Vilskersts, Reinis; Aluja, David; Andreadou, Ioanna; Bencsik, Péter; Dambrova, Maija; Efentakis, Panagiotis; Gao, Fei; Giricz, Zoltán; Inserte, Javier; Kelly-Laubscher, Roisin; Kiss, Attila; Krieg, Thomas; Kwak, Brenda R; Lecour, Sandrine; Lopaschuk, Gary; Mączewski, Michał; Waszkiewicz, Michał; Oknińska, Marta; Pagliaro, Pasquale; Podesser, Bruno; Prag, Hiran A; Ruiz-Meana, Marisol; Szabados, Tamara; Zuurbier, Coert J; Ferdinandy, Péter; Hausenloy, Derek J | |
| Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: Role of cardiac redox signaling | 2021 | Andreadou I.; Daiber A.; Baxter G.F.; Brizzi M.F.; Di Lisa F.; Kaludercic N.; Lazou A.; Varga Z.V.; Zuurbier C.J.; Schulz R.; Ferdinandy P. | |
| Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation? | 2024 | Bellofatto I.A.; Nikolaou P.E.; Andreadou I.; Canepa M.; Carbone F.; Ghigo A.; Heusch G.; Kleinbongard P.; Maack C.; Podesser B.K.; Stamatelopoulos K.; Stellos K.; Vilahur G.; Montecucco F.; Liberale L. |